Barclays set a €24.50 ($28.49) price objective on Evonik Industries (FRA:EVK) in a research report released on Thursday, September 26th, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
Other analysts also recently issued research reports about the company. Berenberg Bank set a €29.00 ($33.72) target price on Evonik Industries and gave the stock a buy rating in a research note on Tuesday, August 20th. DZ Bank reiterated a buy rating on shares of Evonik Industries in a research report on Wednesday, August 7th. Morgan Stanley set a €34.00 ($39.53) price target on Evonik Industries and gave the stock a buy rating in a research report on Monday, July 15th. Independent Research set a €25.00 ($29.07) price target on Evonik Industries and gave the stock a neutral rating in a research report on Wednesday, August 7th. Finally, Bank of America set a €24.00 ($27.91) target price on Evonik Industries and gave the company a sell rating in a research report on Friday, September 20th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the stock. Evonik Industries has an average rating of Hold and an average price target of €28.93 ($33.64).
Shares of EVK stock traded up €0.70 ($0.81) during mid-day trading on Thursday, reaching €22.77 ($26.48). The stock had a trading volume of 821,516 shares. Evonik Industries has a 1-year low of €26.78 ($31.14) and a 1-year high of €32.97 ($38.34). The business’s fifty day moving average is €22.76 and its 200-day moving average is €24.53.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Read More: How to execute a trade ex-dividend strategy?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.